Title : Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.

Pub. Date : 2005 Dec

PMID : 16356805






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Standard treatment (statin) with a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor (pravastatin 40 mg/day) resulted in a 22% reduction in LDL cholesterol levels at 30 days compared with a 51% reduction with intensive therapy (atorvastatin 80 mg/day). Atorvastatin 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens